Cargando…

Progression of Parkinson's Disease Pathology Is Reproduced by Intragastric Administration of Rotenone in Mice

In patients with Parkinson's disease (PD), the associated pathology follows a characteristic pattern involving inter alia the enteric nervous system (ENS), the dorsal motor nucleus of the vagus (DMV), the intermediolateral nucleus of the spinal cord and the substantia nigra, providing the basis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pan-Montojo, Francisco, Anichtchik, Oleg, Dening, Yanina, Knels, Lilla, Pursche, Stefan, Jung, Roland, Jackson, Sandra, Gille, Gabriele, Spillantini, Maria Grazia, Reichmann, Heinz, Funk, Richard H. W.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2808242/ https://www.ncbi.nlm.nih.gov/pubmed/20098733 http://dx.doi.org/10.1371/journal.pone.0008762

Ejemplares similares

Changes in the sympathetic innervation of the gut in rotenone treated mice as possible early biomarker for Parkinson’s disease
por: Arnhold, Mike, et al.
Publicado: (2016)

Pathophysiological Changes in the Enteric Nervous System of Rotenone-Exposed Mice as Early Radiological Markers for Parkinson's Disease
por: Schaffernicht, Gabriela, et al.
Publicado: (2021)

Non-Reproducibility of Oral Rotenone as a Model for Parkinson’s Disease in Mice
por: Niederberger, Ellen, et al.
Publicado: (2022)

Considerations on the role of environmental toxins in idiopathic Parkinson’s disease pathophysiology
por: Pan-Montojo, Francisco, et al.
Publicado: (2014)

The rat rotenone model reproduces the abnormal pattern of central catecholamine metabolism found in Parkinson's disease
por: Landau, Regev, et al.
Publicado: (2022)

Rotenone, Paraquat, and Parkinson’s Disease
por: Tanner, Caroline M., et al.
Publicado: (2011)

The influence of sublethal blue light exposure on human RPE cells
por: Roehlecke, Cora, et al.
Publicado: (2009)

The role of autophagy in Parkinson's disease: rotenone-based modeling
por: Xiong, Nian, et al.
Publicado: (2013)

Piracetam and vinpocetine ameliorate rotenone-induced Parkinsonism in rats
por: Zaitone, Sawsan A., et al.
Publicado: (2012)

Influence of blue light on photoreceptors in a live retinal explant system
por: Roehlecke, Cora, et al.
Publicado: (2011)

Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson’s disease model
por: Wegrzynowicz, Michal, et al.
Publicado: (2019)

Potent Stimulation of Blood Flow in Fingers of Volunteers after Local Short-Term Treatment with Low-Frequency Magnetic Fields from a Novel Device
por: Funk, Richard H. W., et al.
Publicado: (2014)

Chronic Systemic Exposure to Low-Dose Rotenone Induced Central and Peripheral Neuropathology and Motor Deficits in Mice: Reproducible Animal Model of Parkinson’s Disease
por: Miyazaki, Ikuko, et al.
Publicado: (2020)

Neuroprotective potential of ferulic acid in the rotenone model of Parkinson’s disease
por: Ojha, Shreesh, et al.
Publicado: (2015)

Monoterpenoid Epoxidiol Ameliorates the Pathological Phenotypes of the Rotenone-Induced Parkinson’s Disease Model by Alleviating Mitochondrial Dysfunction
por: Aleksandrova, Yulia, et al.
Publicado: (2023)

Edaravone Guards Dopamine Neurons in a Rotenone Model for Parkinson's Disease
por: Xiong, Nian, et al.
Publicado: (2011)

Stereotaxical Infusion of Rotenone: A Reliable Rodent Model for Parkinson's Disease
por: Xiong, Nian, et al.
Publicado: (2009)

Gastrodin inhibits neuroinflammation in rotenone-induced Parkinson's disease model rats★
por: Li, Chun, et al.
Publicado: (2012)

Evidence of Oropharyngeal Dysfunction in Feeding in the Rat Rotenone Model of Parkinson's Disease
por: Gould, François D. H., et al.
Publicado: (2018)

Intragastric Balloon Rupture
por: Lim, George, et al.
Publicado: (2014)

Manual of Intragastric Technique
Publicado: (1903)

Excessive levels of nitric oxide in rat model of Parkinson’s disease induced by rotenone
por: XIONG, ZHONG-KUI, et al.
Publicado: (2015)

Treadmill exercise alleviates depressive symptoms in rotenone-induced Parkinson disease rats
por: Shin, Mal-Soon, et al.
Publicado: (2017)

Olfactory impairment is related to REM sleep deprivation in rotenone model of Parkinson's disease
por: Aurich, Mariana F., et al.
Publicado: (2017)

Involvement of Akt/mTOR in the Neurotoxicity of Rotenone-Induced Parkinson’s Disease Models
por: Zhang, Yu, et al.
Publicado: (2019)

Neuroprotective effects of Danshensu on rotenone-induced Parkinson’s disease models in vitro and in vivo
por: Wang, Tian, et al.
Publicado: (2020)

Neuroprotective effects of linagliptin in a rotenone-induced rat model of Parkinson's disease
por: Abhangi, Kinjal V, et al.
Publicado: (2022)

Neuroprotective effects of curcumin on the cerebellum in a rotenone‐induced Parkinson’s Disease Model
por: Fikry, Heba, et al.
Publicado: (2022)

Neuroprotective and therapeutic effects of calcitriol in rotenone-induced Parkinson’s disease rat model
por: Magdy, Alshimaa, et al.
Publicado: (2022)

Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice
por: Pan-Montojo, Francisco, et al.
Publicado: (2012)

Intragastric Balloon for Overweight Patients
por: Martins Fernandes, Flavio Augusto, et al.
Publicado: (2016)

Mechanistic Investigations of the Mitochondrial Complex I Inhibitor Rotenone in the Context of Pharmacological and Safety Evaluation
por: Heinz, Sabrina, et al.
Publicado: (2017)

CSPα reduces aggregates and rescues striatal dopamine release in α-synuclein transgenic mice
por: Caló, Laura, et al.
Publicado: (2021)

Cell Cycle Regulation of DNA Polymerase Beta in Rotenone-Based Parkinson's Disease Models
por: Wang, Hongcai, et al.
Publicado: (2014)

Acteoside Binds to Caspase-3 and Exerts Neuroprotection in the Rotenone Rat Model of Parkinson's Disease
por: Yuan, Jiawen, et al.
Publicado: (2016)

Differences in brain pathological changes between rotenone and 6-hydroxydopamine Parkinson’s disease models
por: Liu, Lan-Xiang, et al.
Publicado: (2018)

Anti-inflammatory and Anti-oxidant Activity of Hidrox(®) in Rotenone-Induced Parkinson’s Disease in Mice
por: Siracusa, Rosalba, et al.
Publicado: (2020)

Propionic Acid and Fasudil as Treatment against Rotenone Toxicity in an In Vitro Model of Parkinson’s Disease
por: Ostendorf, Friederike, et al.
Publicado: (2020)

Microglial activation contributes to cognitive impairments in rotenone-induced mouse Parkinson’s disease model
por: Zhang, Dongdong, et al.
Publicado: (2021)

Taste Impairments in a Parkinson’s Disease Model Featuring Intranasal Rotenone Administration in Mice
por: Yin, Dong Xu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gn60egos1tfko2s4dj4jhefqrj